Encoded Therapeutics

Drug Discovery

Encoded Therapeutics is a private drug discovery company. It was valued at $1.8 billion at its Series F in Sep 2026, the last priced event on record. It has raised $275 million across 2 recorded rounds; the latest was a $275 million Series F in Sep 2026.

PMV mark · valuation
$1.8B
Oct 2026
Priced at
its Series F
Sep 2026
Total raised
$275.0M
Last round
Series F
Sep 2026

Who backs Encoded Therapeutics?

9 investors
InvestorType
ARCH Venture PartnersVenture capital
VenrockVenture capital
Illumina VenturesVenture capital
RTW InvestmentsHedge fund
Farallon Capital ManagementHedge fund
Matrix Capital ManagementHedge fund
BraidwellHedge fund
Nolan CapitalFamily office
Softbank Vision FundVenture capital
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Encoded Therapeutics investors

9 investors are on record for Encoded Therapeutics, including ARCH Venture Partners, Venrock, Illumina Ventures and RTW Investments. By type, the record holds 4 venture capital firms, 4 hedge funds and 1 family office. The Series F in Sep 2026 drew 12 investors.

Free account
More of Encoded Therapeutics with a free account
  • ·The post-money valuation on its round
  • ·Watch Encoded Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Encoded Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View